Naser Al Yammahi, Deputy CEO of Hayat Biotech, has been named by Forbes Middle East as one of the top 100 healthcare leaders 2024 in the MENA region; placing as #33. This placement is a true testament to Al Yammahi’s commitment to exceptional leadership and dedication to taking Hayat Biotech to new frontiers.
In 2021, Al Yammahi led the establishment of Hayat Biotech, developed the Life Sciences Park in Abu Dhabi, and a manufacturing plant in Serbia. In March 2024, the company partnered with the Kenya BioVax Institute for vaccine R&D. Al Yammahi helped launch the 4Humanity campaign and oversaw the rollout of Hayat Vax, the first Arab-produced Covid-19 vaccine. Alyammahi also previously served as acting executive director and director of projects at the U.A.E. Office of the Minister of State.
For full article, please visit: https://www.linkedin.com/feed/update/urn:li:activity:7240383905730572288/?actorCompanyId=82005720